Share Price and Basic Stock Data
Last Updated: February 14, 2026, 8:31 pm
| PEG Ratio | 3.04 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Cera Sanitaryware Ltd operates in the ceramics, tiles, and sanitaryware industry, with its stock price currently standing at ₹5,287 and a market capitalization of ₹6,824 Cr. The company reported a total revenue of ₹1,803 Cr for the fiscal year ending March 2023, which rose to ₹1,871 Cr in March 2024, and further increased to ₹1,915 Cr for March 2025. The trailing twelve months (TTM) revenue stood at ₹1,935 Cr, indicating a robust growth trajectory. Quarterly sales figures showed some fluctuations, with a peak of ₹547 Cr in March 2024, followed by a decline to ₹398 Cr in June 2024, before rebounding to ₹490 Cr by September 2024. Such revenue variability suggests sensitivity to market conditions, yet the overall upward trend showcases Cera’s strong market positioning.
Profitability and Efficiency Metrics
Profitability metrics for Cera Sanitaryware indicate a healthy operating profit margin (OPM) of 10% as of the latest reporting period. The company recorded a net profit of ₹235 Cr for the fiscal year ending March 2025, reflecting a net profit margin of 12.91%. The return on equity (ROE) stood at 18.3%, while return on capital employed (ROCE) was reported at 22.4%, indicating effective capital utilization. However, operating profit has shown volatility, with a peak operating profit of ₹106 Cr in March 2025, contrasted by a low of ₹51 Cr in December 2025. The cash conversion cycle (CCC) was reported at 137 days, which is relatively high, indicating potential inefficiencies in working capital management compared to typical sector norms. Nevertheless, the interest coverage ratio (ICR) of 48.10x demonstrates Cera’s ability to cover interest expenses comfortably.
Balance Sheet Strength and Financial Ratios
Cera Sanitaryware’s balance sheet reflects a strong financial position, with total assets amounting to ₹1,841 Cr as of March 2025. The company maintains a conservative capital structure, with borrowings reported at ₹60 Cr, resulting in a total debt-to-equity ratio of merely 0.01, which is significantly lower than industry averages. The reserves have increased to ₹1,364 Cr, supporting the company’s growth initiatives and capacity to absorb shocks. Additionally, the price-to-book value (P/BV) stood at 5.37x, indicating that investors are willing to pay a premium for the company’s equity, reflecting confidence in its future growth prospects. The current ratio of 3.82x indicates robust liquidity, ensuring that Cera can meet its short-term obligations effectively.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Cera Sanitaryware illustrates a balanced distribution of ownership among promoters, foreign institutional investors (FIIs), domestic institutional investors (DIIs), and the public. Promoters hold a significant 54.41% stake, ensuring stable management control. FIIs have decreased their stake from 20.92% in September 2023 to 15.83% by September 2025, indicating a potential reduction in foreign investor confidence. Conversely, DIIs have increased their holdings to 13.55%, suggesting a growing interest from domestic institutional players. The total number of shareholders has declined to 1,47,987, reflecting a consolidation of ownership. This mixed sentiment can impact stock performance, as institutional investment often signifies confidence in a company’s long-term viability.
Outlook, Risks, and Final Insight
Looking forward, Cera Sanitaryware’s growth prospects appear promising, bolstered by its strong financial metrics and market position. However, the company faces risks including market volatility, which could impact sales and profitability, as evidenced by fluctuating quarterly revenues. Additionally, the high cash conversion cycle may hinder operational efficiency, potentially leading to liquidity issues in adverse conditions. The increasing competition in the ceramics industry could also squeeze margins. If Cera can address these operational challenges while leveraging its financial strength, it is well-positioned for sustained growth. Conversely, failure to manage these risks could adversely affect its profitability and market position, necessitating vigilance from investors.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Exxaro Tiles Ltd | 325 Cr. | 7.27 | 11.0/5.22 | 68.0 | 6.21 | 0.00 % | 3.49 % | 0.26 % | 1.00 |
| Carysil Ltd | 2,775 Cr. | 976 | 1,072/482 | 30.7 | 199 | 0.25 % | 15.4 % | 14.5 % | 2.00 |
| Somany Ceramics Ltd | 1,649 Cr. | 402 | 624/359 | 25.5 | 191 | 0.75 % | 11.5 % | 8.17 % | 2.00 |
| Orient Bell Ltd | 434 Cr. | 295 | 350/215 | 48.4 | 217 | 0.17 % | 2.38 % | 0.90 % | 10.0 |
| Nitco Ltd | 1,844 Cr. | 80.5 | 164/76.0 | 48.8 | 13.2 | 0.00 % | 42.9 % | % | 10.0 |
| Industry Average | 3,377.78 Cr | 795.10 | 36.91 | 200.52 | 0.48% | 12.44% | 14.63% | 6.10 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 456 | 533 | 427 | 461 | 437 | 547 | 398 | 490 | 449 | 578 | 419 | 488 | 499 |
| Expenses | 383 | 445 | 358 | 387 | 377 | 455 | 342 | 420 | 390 | 472 | 366 | 421 | 448 |
| Operating Profit | 73 | 88 | 68 | 74 | 59 | 92 | 56 | 70 | 59 | 106 | 53 | 67 | 51 |
| OPM % | 16% | 17% | 16% | 16% | 14% | 17% | 14% | 14% | 13% | 18% | 13% | 14% | 10% |
| Other Income | 14 | 5 | 16 | 11 | 16 | 16 | 16 | 18 | 12 | 14 | 19 | 17 | -7 |
| Interest | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 2 | 1 | 2 | 2 |
| Depreciation | 8 | 8 | 8 | 8 | 9 | 9 | 8 | 10 | 10 | 10 | 9 | 10 | 10 |
| Profit before tax | 77 | 83 | 75 | 76 | 65 | 98 | 63 | 75 | 60 | 108 | 61 | 72 | 32 |
| Tax % | 27% | 25% | 25% | 25% | 22% | 23% | 25% | 10% | 23% | 21% | 24% | 22% | 27% |
| Net Profit | 56 | 63 | 56 | 57 | 51 | 75 | 47 | 68 | 46 | 86 | 47 | 57 | 24 |
| EPS in Rs | 43.34 | 48.39 | 43.34 | 43.74 | 39.12 | 57.69 | 36.11 | 52.79 | 35.56 | 66.35 | 36.08 | 43.92 | 18.35 |
Last Updated: February 6, 2026, 9:16 am
Below is a detailed analysis of the quarterly data for Cera Sanitaryware Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 499.00 Cr.. The value appears strong and on an upward trend. It has increased from 488.00 Cr. (Sep 2025) to 499.00 Cr., marking an increase of 11.00 Cr..
- For Expenses, as of Dec 2025, the value is 448.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 421.00 Cr. (Sep 2025) to 448.00 Cr., marking an increase of 27.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Sep 2025) to 51.00 Cr., marking a decrease of 16.00 Cr..
- For OPM %, as of Dec 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 14.00% (Sep 2025) to 10.00%, marking a decrease of 4.00%.
- For Other Income, as of Dec 2025, the value is -7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Sep 2025) to -7.00 Cr., marking a decrease of 24.00 Cr..
- For Interest, as of Dec 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 2.00 Cr..
- For Depreciation, as of Dec 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 10.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 32.00 Cr.. The value appears to be declining and may need further review. It has decreased from 72.00 Cr. (Sep 2025) to 32.00 Cr., marking a decrease of 40.00 Cr..
- For Tax %, as of Dec 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 22.00% (Sep 2025) to 27.00%, marking an increase of 5.00%.
- For Net Profit, as of Dec 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Sep 2025) to 24.00 Cr., marking a decrease of 33.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 18.35. The value appears to be declining and may need further review. It has decreased from 43.92 (Sep 2025) to 18.35, marking a decrease of 25.57.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:31 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 664 | 822 | 917 | 1,011 | 1,182 | 1,344 | 1,209 | 1,202 | 1,442 | 1,803 | 1,871 | 1,915 | 1,935 |
| Expenses | 569 | 703 | 776 | 841 | 1,014 | 1,152 | 1,045 | 1,052 | 1,220 | 1,510 | 1,577 | 1,622 | 1,649 |
| Operating Profit | 95 | 119 | 141 | 171 | 168 | 191 | 164 | 150 | 221 | 293 | 295 | 293 | 285 |
| OPM % | 14% | 14% | 15% | 17% | 14% | 14% | 14% | 12% | 15% | 16% | 16% | 15% | 15% |
| Other Income | 6 | 5 | 10 | 11 | 14 | 15 | 14 | 22 | 17 | 25 | 59 | 59 | 62 |
| Interest | 6 | 8 | 5 | 5 | 5 | 3 | 4 | 4 | 5 | 5 | 5 | 7 | 7 |
| Depreciation | 12 | 15 | 16 | 18 | 22 | 23 | 33 | 33 | 30 | 30 | 34 | 39 | 39 |
| Profit before tax | 82 | 101 | 129 | 158 | 154 | 180 | 141 | 134 | 203 | 282 | 314 | 306 | 301 |
| Tax % | 37% | 33% | 36% | 34% | 35% | 36% | 18% | 25% | 27% | 26% | 24% | 19% | |
| Net Profit | 52 | 68 | 83 | 104 | 100 | 115 | 116 | 101 | 149 | 210 | 239 | 246 | 235 |
| EPS in Rs | 41.02 | 52.02 | 64.17 | 79.94 | 77.08 | 88.46 | 89.14 | 77.89 | 114.84 | 161.20 | 183.89 | 191.11 | 181.91 |
| Dividend Payout % | 12% | 12% | 14% | 15% | 16% | 15% | 15% | 17% | 30% | 31% | 33% | 34% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 30.77% | 22.06% | 25.30% | -3.85% | 15.00% | 0.87% | -12.93% | 47.52% | 40.94% | 13.81% | 2.93% |
| Change in YoY Net Profit Growth (%) | 0.00% | -8.71% | 3.24% | -29.15% | 18.85% | -14.13% | -13.80% | 60.46% | -6.59% | -27.13% | -10.88% |
Cera Sanitaryware Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 10% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 16% |
| 3 Years: | 17% |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 21% |
| 3 Years: | 6% |
| 1 Year: | -32% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 17% |
| 3 Years: | 19% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 1:45 am
Balance Sheet
Last Updated: December 4, 2025, 1:06 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 218 | 345 | 415 | 518 | 598 | 694 | 766 | 868 | 999 | 1,163 | 1,336 | 1,344 | 1,364 |
| Borrowings | 48 | 68 | 35 | 34 | 24 | 18 | 33 | 28 | 37 | 46 | 40 | 63 | 60 |
| Other Liabilities | 181 | 224 | 290 | 302 | 320 | 371 | 320 | 381 | 385 | 441 | 443 | 427 | 383 |
| Total Liabilities | 453 | 644 | 747 | 861 | 949 | 1,089 | 1,126 | 1,283 | 1,427 | 1,656 | 1,825 | 1,841 | 1,814 |
| Fixed Assets | 152 | 215 | 226 | 266 | 279 | 305 | 350 | 330 | 321 | 320 | 356 | 380 | 375 |
| CWIP | 5 | 8 | 4 | 0 | 5 | 11 | 1 | 1 | 1 | 17 | 13 | 11 | 9 |
| Investments | 12 | 48 | 67 | 119 | 139 | 212 | 262 | 513 | 567 | 669 | 807 | 702 | 712 |
| Other Assets | 284 | 374 | 449 | 475 | 525 | 561 | 512 | 440 | 539 | 649 | 649 | 749 | 718 |
| Total Assets | 453 | 644 | 747 | 861 | 949 | 1,089 | 1,126 | 1,283 | 1,427 | 1,656 | 1,825 | 1,841 | 1,814 |
Below is a detailed analysis of the balance sheet data for Cera Sanitaryware Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,364.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,344.00 Cr. (Mar 2025) to 1,364.00 Cr., marking an increase of 20.00 Cr..
- For Borrowings, as of Sep 2025, the value is 60.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 63.00 Cr. (Mar 2025) to 60.00 Cr., marking a decrease of 3.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 383.00 Cr.. The value appears to be improving (decreasing). It has decreased from 427.00 Cr. (Mar 2025) to 383.00 Cr., marking a decrease of 44.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,814.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,841.00 Cr. (Mar 2025) to 1,814.00 Cr., marking a decrease of 27.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 375.00 Cr.. The value appears to be declining and may need further review. It has decreased from 380.00 Cr. (Mar 2025) to 375.00 Cr., marking a decrease of 5.00 Cr..
- For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 712.00 Cr.. The value appears strong and on an upward trend. It has increased from 702.00 Cr. (Mar 2025) to 712.00 Cr., marking an increase of 10.00 Cr..
- For Other Assets, as of Sep 2025, the value is 718.00 Cr.. The value appears to be declining and may need further review. It has decreased from 749.00 Cr. (Mar 2025) to 718.00 Cr., marking a decrease of 31.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,814.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,841.00 Cr. (Mar 2025) to 1,814.00 Cr., marking a decrease of 27.00 Cr..
Notably, the Reserves (1,364.00 Cr.) exceed the Borrowings (60.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 47.00 | 51.00 | 106.00 | 137.00 | 144.00 | 173.00 | 131.00 | 122.00 | 184.00 | 247.00 | 255.00 | 230.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 59 | 72 | 75 | 80 | 83 | 81 | 67 | 63 | 42 | 38 | 39 | 51 |
| Inventory Days | 125 | 120 | 109 | 98 | 104 | 101 | 128 | 96 | 154 | 167 | 148 | 163 |
| Days Payable | 45 | 46 | 48 | 58 | 50 | 53 | 52 | 81 | 104 | 93 | 75 | 77 |
| Cash Conversion Cycle | 139 | 145 | 137 | 120 | 136 | 129 | 142 | 78 | 92 | 112 | 112 | 137 |
| Working Capital Days | 33 | 43 | 47 | 43 | 56 | 58 | 66 | 30 | 37 | 43 | 44 | 65 |
| ROCE % | 35% | 32% | 30% | 31% | 26% | 27% | 19% | 16% | 22% | 26% | 25% | 22% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HSBC Small Cap Fund | 338,650 | 1.11 | 177.3 | N/A | N/A | N/A |
| Canara Robeco Small Cap Fund | 304,497 | 1.22 | 159.42 | 218,823 | 2025-12-07 15:33:48 | 39.15% |
| UTI Value Fund | 135,000 | 0.7 | 70.68 | 108,291 | 2026-01-25 03:26:06 | 24.66% |
| Bandhan Flexi Cap Fund | 75,000 | 0.51 | 39.27 | 65,002 | 2026-01-25 04:19:52 | 15.38% |
| Canara Robeco Multi Cap Fund | 74,675 | 0.76 | 39.1 | N/A | N/A | N/A |
| UTI Small Cap Fund | 69,170 | 0.76 | 36.21 | N/A | N/A | N/A |
| UTI Dividend Yield Fund | 60,000 | 0.8 | 31.41 | 40,941 | 2026-01-25 09:02:40 | 46.55% |
| Tata India Consumer Fund | 59,631 | 1.17 | 31.22 | 55,691 | 2025-12-15 06:58:38 | 7.07% |
| Edelweiss Small Cap Fund | 55,965 | 0.58 | 30.99 | N/A | N/A | N/A |
| UTI ELSS Tax Saver Fund | 47,717 | 0.66 | 24.98 | 36,418 | 2026-01-25 16:48:10 | 31.03% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 190.40 | 183.76 | 161.01 | 116.18 | 77.48 |
| Diluted EPS (Rs.) | 190.40 | 183.76 | 161.01 | 116.18 | 77.48 |
| Cash EPS (Rs.) | 224.36 | 213.65 | 187.35 | 142.51 | 107.24 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1049.48 | 1044.56 | 909.79 | 791.48 | 679.28 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1049.48 | 1044.56 | 909.79 | 791.48 | 679.28 |
| Revenue From Operations / Share (Rs.) | 1493.42 | 1445.06 | 1386.69 | 1111.68 | 941.37 |
| PBDIT / Share (Rs.) | 279.40 | 278.93 | 252.61 | 194.05 | 140.87 |
| PBIT / Share (Rs.) | 247.87 | 250.83 | 227.54 | 169.13 | 110.45 |
| PBT / Share (Rs.) | 240.90 | 245.16 | 219.04 | 160.66 | 102.97 |
| Net Profit / Share (Rs.) | 192.83 | 185.55 | 162.27 | 117.60 | 76.82 |
| NP After MI And SOA / Share (Rs.) | 191.10 | 183.77 | 161.01 | 116.18 | 77.48 |
| PBDIT Margin (%) | 18.70 | 19.30 | 18.21 | 17.45 | 14.96 |
| PBIT Margin (%) | 16.59 | 17.35 | 16.40 | 15.21 | 11.73 |
| PBT Margin (%) | 16.13 | 16.96 | 15.79 | 14.45 | 10.93 |
| Net Profit Margin (%) | 12.91 | 12.84 | 11.70 | 10.57 | 8.16 |
| NP After MI And SOA Margin (%) | 12.79 | 12.71 | 11.61 | 10.45 | 8.23 |
| Return on Networth / Equity (%) | 18.20 | 17.75 | 17.85 | 14.88 | 11.56 |
| Return on Capital Employeed (%) | 21.43 | 22.26 | 23.06 | 19.66 | 14.29 |
| Return On Assets (%) | 13.23 | 12.95 | 12.48 | 9.73 | 7.31 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.02 | 0.02 | 0.05 |
| Asset Turnover Ratio (%) | 1.04 | 1.07 | 1.12 | 1.03 | 0.96 |
| Current Ratio (X) | 3.82 | 3.74 | 3.24 | 2.68 | 2.42 |
| Quick Ratio (X) | 2.72 | 2.79 | 2.27 | 2.01 | 1.88 |
| Inventory Turnover Ratio (X) | 4.98 | 0.67 | 0.76 | 0.72 | 0.41 |
| Dividend Payout Ratio (NP) (%) | 31.65 | 27.20 | 21.73 | 11.18 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 27.17 | 23.59 | 18.80 | 9.21 | 0.00 |
| Earning Retention Ratio (%) | 68.35 | 72.80 | 78.27 | 88.82 | 0.00 |
| Cash Earning Retention Ratio (%) | 72.83 | 76.41 | 81.20 | 90.79 | 0.00 |
| Interest Coverage Ratio (X) | 48.10 | 62.32 | 54.32 | 47.79 | 18.83 |
| Interest Coverage Ratio (Post Tax) (X) | 34.40 | 42.72 | 36.72 | 31.05 | 11.27 |
| Enterprise Value (Cr.) | 7272.80 | 8811.02 | 8314.10 | 6496.10 | 5152.10 |
| EV / Net Operating Revenue (X) | 3.78 | 4.69 | 4.61 | 4.49 | 4.21 |
| EV / EBITDA (X) | 20.18 | 24.29 | 25.31 | 25.74 | 28.12 |
| MarketCap / Net Operating Revenue (X) | 3.78 | 4.69 | 4.60 | 4.47 | 4.15 |
| Retention Ratios (%) | 68.34 | 72.79 | 78.26 | 88.81 | 0.00 |
| Price / BV (X) | 5.37 | 6.55 | 7.08 | 6.37 | 5.83 |
| Price / Net Operating Revenue (X) | 3.78 | 4.69 | 4.60 | 4.47 | 4.15 |
| EarningsYield | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 |
After reviewing the key financial ratios for Cera Sanitaryware Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 190.40. This value is within the healthy range. It has increased from 183.76 (Mar 24) to 190.40, marking an increase of 6.64.
- For Diluted EPS (Rs.), as of Mar 25, the value is 190.40. This value is within the healthy range. It has increased from 183.76 (Mar 24) to 190.40, marking an increase of 6.64.
- For Cash EPS (Rs.), as of Mar 25, the value is 224.36. This value is within the healthy range. It has increased from 213.65 (Mar 24) to 224.36, marking an increase of 10.71.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,049.48. It has increased from 1,044.56 (Mar 24) to 1,049.48, marking an increase of 4.92.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,049.48. It has increased from 1,044.56 (Mar 24) to 1,049.48, marking an increase of 4.92.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,493.42. It has increased from 1,445.06 (Mar 24) to 1,493.42, marking an increase of 48.36.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 279.40. This value is within the healthy range. It has increased from 278.93 (Mar 24) to 279.40, marking an increase of 0.47.
- For PBIT / Share (Rs.), as of Mar 25, the value is 247.87. This value is within the healthy range. It has decreased from 250.83 (Mar 24) to 247.87, marking a decrease of 2.96.
- For PBT / Share (Rs.), as of Mar 25, the value is 240.90. This value is within the healthy range. It has decreased from 245.16 (Mar 24) to 240.90, marking a decrease of 4.26.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 192.83. This value is within the healthy range. It has increased from 185.55 (Mar 24) to 192.83, marking an increase of 7.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 191.10. This value is within the healthy range. It has increased from 183.77 (Mar 24) to 191.10, marking an increase of 7.33.
- For PBDIT Margin (%), as of Mar 25, the value is 18.70. This value is within the healthy range. It has decreased from 19.30 (Mar 24) to 18.70, marking a decrease of 0.60.
- For PBIT Margin (%), as of Mar 25, the value is 16.59. This value is within the healthy range. It has decreased from 17.35 (Mar 24) to 16.59, marking a decrease of 0.76.
- For PBT Margin (%), as of Mar 25, the value is 16.13. This value is within the healthy range. It has decreased from 16.96 (Mar 24) to 16.13, marking a decrease of 0.83.
- For Net Profit Margin (%), as of Mar 25, the value is 12.91. This value exceeds the healthy maximum of 10. It has increased from 12.84 (Mar 24) to 12.91, marking an increase of 0.07.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.79. This value is within the healthy range. It has increased from 12.71 (Mar 24) to 12.79, marking an increase of 0.08.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.20. This value is within the healthy range. It has increased from 17.75 (Mar 24) to 18.20, marking an increase of 0.45.
- For Return on Capital Employeed (%), as of Mar 25, the value is 21.43. This value is within the healthy range. It has decreased from 22.26 (Mar 24) to 21.43, marking a decrease of 0.83.
- For Return On Assets (%), as of Mar 25, the value is 13.23. This value is within the healthy range. It has increased from 12.95 (Mar 24) to 13.23, marking an increase of 0.28.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.04. It has decreased from 1.07 (Mar 24) to 1.04, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 3.82. This value exceeds the healthy maximum of 3. It has increased from 3.74 (Mar 24) to 3.82, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 2.72. This value exceeds the healthy maximum of 2. It has decreased from 2.79 (Mar 24) to 2.72, marking a decrease of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.98. This value is within the healthy range. It has increased from 0.67 (Mar 24) to 4.98, marking an increase of 4.31.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 31.65. This value is within the healthy range. It has increased from 27.20 (Mar 24) to 31.65, marking an increase of 4.45.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 27.17. This value is within the healthy range. It has increased from 23.59 (Mar 24) to 27.17, marking an increase of 3.58.
- For Earning Retention Ratio (%), as of Mar 25, the value is 68.35. This value is within the healthy range. It has decreased from 72.80 (Mar 24) to 68.35, marking a decrease of 4.45.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 72.83. This value exceeds the healthy maximum of 70. It has decreased from 76.41 (Mar 24) to 72.83, marking a decrease of 3.58.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 48.10. This value is within the healthy range. It has decreased from 62.32 (Mar 24) to 48.10, marking a decrease of 14.22.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 34.40. This value is within the healthy range. It has decreased from 42.72 (Mar 24) to 34.40, marking a decrease of 8.32.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,272.80. It has decreased from 8,811.02 (Mar 24) to 7,272.80, marking a decrease of 1,538.22.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.69 (Mar 24) to 3.78, marking a decrease of 0.91.
- For EV / EBITDA (X), as of Mar 25, the value is 20.18. This value exceeds the healthy maximum of 15. It has decreased from 24.29 (Mar 24) to 20.18, marking a decrease of 4.11.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.69 (Mar 24) to 3.78, marking a decrease of 0.91.
- For Retention Ratios (%), as of Mar 25, the value is 68.34. This value is within the healthy range. It has decreased from 72.79 (Mar 24) to 68.34, marking a decrease of 4.45.
- For Price / BV (X), as of Mar 25, the value is 5.37. This value exceeds the healthy maximum of 3. It has decreased from 6.55 (Mar 24) to 5.37, marking a decrease of 1.18.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.69 (Mar 24) to 3.78, marking a decrease of 0.91.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cera Sanitaryware Ltd:
- Net Profit Margin: 12.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21.43% (Industry Average ROCE: 12.44%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.2% (Industry Average ROE: 14.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 34.4
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 29.3 (Industry average Stock P/E: 36.91)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.91%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Ceramics/Tiles/Sanitaryware | 9, GIDC Industrial Estate, Mehsana Dist. Gujarat 382715 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vikram Somany | Chairman & Managing Director |
| Mrs. Deepshikha Khaitan | Vice Chairman & Jt Manag. Dir. |
| Mr. Anupam Gupta | Executive Director -Technical |
| Mr. Surendra Singh Baid | Independent Director |
| Ms. Akriti Jain | Independent Director |
| Mr. Ravi Bhamidipaty | Independent Director |
| Mr. Anandh Sundar | Independent Director |
FAQ
What is the intrinsic value of Cera Sanitaryware Ltd?
Cera Sanitaryware Ltd's intrinsic value (as of 15 February 2026) is ₹5062.62 which is 0.97% lower the current market price of ₹5,112.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹6,593 Cr. market cap, FY2025-2026 high/low of ₹7,275/4,794, reserves of ₹1,364 Cr, and liabilities of ₹1,814 Cr.
What is the Market Cap of Cera Sanitaryware Ltd?
The Market Cap of Cera Sanitaryware Ltd is 6,593 Cr..
What is the current Stock Price of Cera Sanitaryware Ltd as on 15 February 2026?
The current stock price of Cera Sanitaryware Ltd as on 15 February 2026 is ₹5,112.
What is the High / Low of Cera Sanitaryware Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cera Sanitaryware Ltd stocks is ₹7,275/4,794.
What is the Stock P/E of Cera Sanitaryware Ltd?
The Stock P/E of Cera Sanitaryware Ltd is 29.3.
What is the Book Value of Cera Sanitaryware Ltd?
The Book Value of Cera Sanitaryware Ltd is 1,063.
What is the Dividend Yield of Cera Sanitaryware Ltd?
The Dividend Yield of Cera Sanitaryware Ltd is 1.27 %.
What is the ROCE of Cera Sanitaryware Ltd?
The ROCE of Cera Sanitaryware Ltd is 22.4 %.
What is the ROE of Cera Sanitaryware Ltd?
The ROE of Cera Sanitaryware Ltd is 18.3 %.
What is the Face Value of Cera Sanitaryware Ltd?
The Face Value of Cera Sanitaryware Ltd is 5.00.